Quick Answer
TELA Bio, Inc. reported Net Income Loss of -$38.83 million for the year ending 2025.
- TELA Bio, Inc. showed a decrease of -2.6% in Net Income Loss from 2024 to 2025.
- This data is from TELA Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), TELA Bio, Inc.'s Net Income Loss has declined by 82.0%.
- Historical annual values: Fiscal year 2025: -$38.83 million | Fiscal year 2024: -$37.84 million | Fiscal year 2023: -$46.66 million | Fiscal year 2022: -$44.30 million | Fiscal year 2021: -$33.28 million | Fiscal year 2020: -$28.79 million | Fiscal year 2019: -$22.43 million | Fiscal year 2018: -$21.09 million | Fiscal year 2017: -$21.33 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: